
Sophiris Bio (SPHS)
$0.00
Order type
Buy in
Order amount
Est. shares
0 shares
Buy Sophiris Bio (SPHS) Stock
See the latest SPHS stock price, buy/sell Sophiris Bio shares with AI-powered fundamental data and custom analysis.
Start investing in Sophiris Bio (SPHS)
About Sophiris Bio (SPHS)
Sophiris Bio is a biotech company that develops a treatment for the symptoms of benign prostatic hyperplasia. Their product includes topsalysin for the treatment of lower urinary tract symptoms of benign prostatic hyperplasia and for the treatment of low- to intermediate-risk prostate cancer.
Market cap | — |
Today's volume | — |
Revenue (TTM) | — |
Avg. daily volume | 32.26 |
EBITDA (TTM) | — |
Open | — |
Price / earnings ratio | — |
Today's range | — |
Debt / equity | — |
52 week range | — |
5 year debt / equity | — |
Beta (LTM) | 200.63x |
Interest coverage | — |
Dividend & yield | $0.00 (0.00%) |
Current ratio | — |
Ex-dividend date | — |
Next earnings | — |
Dividend payable date | — |
Sophiris Bio Stock News
View allNewsfile Corp •

GlobeNewsWire •

Frequently Asked Questions (FAQ)
The 52-week high for SPHS stock is $0.03. The current SPHS stock price $undefined is 100.00% below its 52-week high
No, the SPHS stock does not pay dividends to its shareholders
How to buy SPHS stock on Public
- 1
Sign up for a brokerage account on Public
It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.
- 2
Add funds to your Public account
There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.
- 3
Choose how much you'd like to invest in SPHS stock
Navigate to the Explore page. Then, type SPHS into the search bar. When you see SPHS stock appear in the results, tap it to open up the purchase screen.
- 4
Manage your investments in one place
You can find your newly purchased SPHS stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.